Conference
Regions for Health Innovation: Personalised Medicine and ATMPs driving Europe’s Future 2026
Start
04.06.2026
End
04.06.2026
Location
European Parliament, Brussels. Room SPINELLI 3H1
Organized by
Sahlgrenska Science Park, Biocat, BIOPRO Baden-Württemberg, Eatris, AstraZeneca
Collaborate
Government of Catalonia, European Union
The European Parliament will host the event “Regions for Health Innovation: Personalised Medicine and ATMPs driving Europe’s Future”, a high-level meeting aimed at highlighting the role of personalised medicine, advanced therapies, and regions as drivers of innovation and competitiveness in Europe.
NOTE: The language of the event will be English.
For more information: internacional@biocat.cat
Program
11:00 - 11:10 | Welcome & Strategic Framing
- Mr. Nikos Papandreou, Member of the European Parliament, Member of the Committee on Public Health (Greece)
- Ms. Esther Borràs, Delegate of the Government of Catalonia to the EU
11:10 - 11:30 | Keynote Address: Delivering Choose Europe for Life Sciences
- Ms. Paschalia Koufokotsiou, ATMP Policy Officer at DG SANTE
11:30 - 11:40 | Briefing: “Market Readiness for Personalised Medicine”
- Dr. Gwen Gilderson, Sahlgrenska Science Park, Gothenburg (Sweden)
11:40 - 12:15 | ATMPs: From Hospital-Based Innovation to Scalable Access
Moderator:
- Dr. Ramon Maspons, Director of Strategy and Health Innovation, Ministry of Health, Government of Catalonia (Spain)
Speakers:
- Ms. Lydia Shotton, Associate Director for Government Affairs, Europe, Alliance for Regenerative Medicine (Belgium)
- Dr. David Morrow, Scientific Lead for Advanced Therapies at EATRIS-ERIC, European infrastructure for translational medicine (Netherlands)
- Dr. Miguel Forte, President of the International Society for Cell & Gene Therapy, CEO and Co-Founder of Kiji Therapeutics (Portugal)
- Elisa Sangiorgi, Head of the Medicines and Medical Devices Division (Italy)
12:15 - 12:50 | Panel 2: “Clinical Trials – Making Europe More Competitive, Efficient & Patient-Oriented”
Moderator:
- Ms. Ebba Hallersjö Hult, Co-founder and Head of Vision Zero Cancer, Member of the Advisory Board of PRECISEU (Sweden)
Speakers:
- Dr. Julio Delgado, Head of the Oncoimmunotherapy Unit, Hospital Clínic de Barcelona (Spain)
- Dr. Juan José Ventura, Research and Patient Engagement Director, Cancer Patients Europe (Belgium)
- Dr. Charlotta Ljungman, Senior Consultant and Associate Professor, Cardiology Center for Precision Medicine, Sahlgrenska University Hospital (Sweden)
- Dr. Robert Fabregat, CEO of Biocat, PRECISEU Coordinating entity (Spain)
12:50 - 13:00 | ynthesis and Policy Takeaways
- Anna-Pia Papageorgiou from Directorate-General for Research and Innovation
13:00 | Refreshments & Networking
Organised by:
With the support of:
Hosted by:
